Patients in England with a specific form of incurable breast cancer can now receive Enhertu on the NHS, after changes to its cost-effectiveness assessment reversed an…
NHS patients could receive some cutting-edge medicines months earlier under new pilot schemes announced by the government in July 2026. The pilots are designed to test…
Cancer waiting time targets are clinical safety benchmarks designed to ensure patients are diagnosed and treated quickly, because earlier treatment is strongly linked to better outcomes.…
NHS England announced in January 2026 that it would create a world-first inherited cancer genetic register. The register is intended to collect information on more than…
The story highlights a problem patients already understand: healthcare access is not always the same everywhere. Where you live can affect how quickly you…
Newly published cancer waiting time statistics show that key targets are being missed at scale, prompting warnings that delays in diagnosis and treatment could…